BJ Rimel (@bjrimelmd) 's Twitter Profile
BJ Rimel

@bjrimelmd

Gyn Oncologist, Medical Director of Cancer Clinical trials Office Cedars-Sinai Medical Center, mom, lesbian, opinions that are tweeted are mine, not Cedars

ID: 2296747100

linkhttp://www.cedars-sinai.edu/researchforher calendar_today17-01-2014 20:45:08

1,1K Tweet

2,2K Followers

1,1K Following

Alexandra Gangi, MD (@agangimd) 's Twitter Profile Photo

Very much looking forward to welcoming Cristina Ferrone 💫 as new Chair of Department of Surgery at Cedars-Sinai Cedars-Sinai in January! Dr. Bruce Gewertz bruce gewertz has propelled us to new heights leaving room for only great things ahead..! #SurgOnc #hpbheroines 👩🏻‍⚕️@CSCancerCare

Very much looking forward to welcoming <a href="/CFerroneMD/">Cristina Ferrone</a> 💫 as new Chair of <a href="/DeptSurgeryCS/">Department of Surgery at Cedars-Sinai</a> <a href="/CedarsSinai/">Cedars-Sinai</a> in January! Dr. Bruce Gewertz <a href="/jackgiraffe1/">bruce gewertz</a> has propelled us to new heights leaving room for only great things ahead..! #SurgOnc #hpbheroines 👩🏻‍⚕️@CSCancerCare
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Mortality from #CervicalCancer is a direct reflection of resource distribution. Future research must account for systemic failures to eradicate inequities in addition to the development of novel agents against this disease. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @bjrimelmd Sarah Temkin

Mortality from #CervicalCancer is a direct reflection of resource distribution. Future research must account for systemic failures to eradicate inequities in addition to the development of novel agents against this disease. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @bjrimelmd <a href="/temkins/">Sarah Temkin</a>
ASCO (@asco) 's Twitter Profile Photo

Update on #drugshortages: Teva has a limited supply of the smaller 50mL vials of cisplatin and availability of the 100mL, with recovery to regular supply levels expected in Q4 and Q3, respectively. Call 800-545-8800 for details.

Annie Ellis (@stigetta) 's Twitter Profile Photo

Gabe Sonke: Final survival analysis of phase III OVHIPEC-1 trial ovarian cancer after ten year follow-up. #ASCO23 #gyncsm

Gabe Sonke: Final survival analysis of phase III OVHIPEC-1 trial ovarian cancer after ten year follow-up. #ASCO23 #gyncsm
@GynOncJnls (@gynoncjnls) 's Twitter Profile Photo

Tyrosine kinase inhibitor use in gynecologic cancer: appropriate management of unique toxicities is crucial🚨BJ Rimel SGO ASCO SGO IGCS ESGO OncoAlert sciencedirect.com/science/articl…